Read our latest publications
Some members of the community have raised concerns about the impact on their health while living near a wind farm.
This information paper summarises the available evidence on the subject along with key issues raised by the public and the expert community.
Examining whether wind farm emissions may affect human health is complex, due to the nature of the emissions and individual perceptions are highly variable. After careful consideration and deliberation of the body of evidence, NHMRC concludes there is currently no consistent evidence that wind farms cause adverse health effects in humans.
Many Australians report they use complementary medicine, but don't tell their clinicians which may impede treatment.
This resource aims to promote discussions between clinicians and patients about complementary medicine and better equip patients to make informed decisions about their health care.
NHMRC has reviewed the scientific evidence for the effectiveness of homeopathy in treating a variety of clinical conditions with the aim of providing Australians with reliable information about its use. This page contains the NHMRC Statement, the Information Paper detailing the evidence as well as an Administrative report.
This annual report is a record of NHMRC's activities during 2013–2014 financial year and the performance and financial information presented in the 2013–14 NHMRC Portfolio Budget Statement and 2013–14 NHMRC Portfolio Additional Estimates Statement.
This document is a five-year analysis of the scientific publication output and citation impact of research funded by NHMRC and of Australian health and medical research generally.
The aim of the report is to measure the impact of NHMRC funding schemes in terms of published journal output.
This document covers the vision and mission statements of NHMRC to improve the health of Australians using exceptional, ethical research.
The strategic plan focuses on stronger integration across research, advice, ethics and regulation to further our goal. Seven key objectives and their strategies and measures are detailed here.
This Strategic Plan outlines five objectives of NHMRC over a three year period. These include raising the standard of public health in Australia and developing consistent standards, fostering relevant research and training and more.
The Plan also outlines 10 major health issues NHMRC focused on over the same three year period.
This Facts Book contains statistics on the outcomes of the 2013 application rounds for NHMRC’s research funding, as well as historical information over the last ten years. NHMRC is committed to transparency regarding the outcomes of its granting system. More detailed statistics and funding data can be found on the NHMRC website under Data on research.
This guide supports the implementation of the Australian code for the care and use of animals for scientific purposes 8th edition (2013) by providing advise about the specific and unique needs of Australian native mammals can be met when these animals are used for scientific purposes.
It provides information for investigators, institutions, animal ethics committees and all those involved in the care and use of Australian native mammals for scientific purposes.
Since 2010 NHMRC has released annual reports on the characteristics of Australian clinical practice guidelines which provide information about who funds and develops clinical practice guidelines, and describe trends in important quality indicators such as the use of evidence and the disclosure of competing interests.
NHMRC sought a review of legal and policy barriers in Australia to promote a competitive and accessible clinical trials sector.
This review details current indemnity and insurance arrangements concerning clinical trials across the public and private sectors.
Quality assurance (QA) and evaluation are important to ensure effective work and the best outcomes. However, confusion arises over if an activity is research, evaluation or QA as there may be similar research methods used.
This document assists organisations in developing QA policy and appropriate oversight.
Genetic tests are easily purchased by consumers, often over the internet and usually without the involvement of a medical professional. These tests can be used in diagnosing medical conditions or pre-dispositions.
The statement highlights issues for medical professionals and consumers regarding the use of health-related genetic testing.
The number of direct to consumer DNA tests consumers can buy over the internet, without the involvement of a doctor, has been rising.
This resource is to inform consumers about test accuracy, privacy legislation and what it may mean for personal insurances and blood relations.
This information has been developed for health practitioners to support discussion with men and their families about prostate-specific antigen testing for prostate cancer.
It covers benefits, possible risks, current research and frequently asked questions.
Despite the use of lead being reduced in many industries, it is still found in many environments and is known to have adverse effects on human health.
This report evaluates the evidence relating to individual level lead exposure in Australia, the effects from this and the effectiveness of intervention strategies.
The Privacy Legislation Amendment Act 2006 (Cth) made changes to the Privacy Act 1988(Cth) (the Privacy Act) to allow health practitioners to disclose patient’s genetic information, whether or not they give consent, in circumstances where there is reasonable belief that doing so is necessary to lessen or prevent a serious threat to the life, health or safety of their genetics relative(s). The amendments do not oblige disclosure of information but provide the framework for this to occur under the appropriate circumstances.
There are concerns about the increasing availability of health-related genetic testing kits. This guide is for health professionals whose patients are considering buying a test kit or want to discuss their results.
Ten of the Best Research Projects 2013 showcases ten Australian health and medical research projects chosen from among the thousands of NHMRC funded medical research projects underway in Australia.
These projects illustrate the extraodinary quality and diversity of work being undertaken with NHMRC support.
Epigenetics has recently become a popular explanation for complex diseases of unknown origin. Epigenetics is the study of mechanisms that control how genes are switched ‘on’ and ‘off’ without any changes in the actual DNA of the cells.
Discrimination against an individual can appear in many forms. As DNA testing increasingly identifies differences in the genetic make-up of individuals, it becomes possible that people will be discriminated against based on genetic information.
Using information about genetic predisposition to disease is a key part of personalised medicine. This resource has been developed to provide information to consumers about personalised medicine and genetics.
DNA testing can be used for a number of purposes not related to health. One area of interest is the potential for DNA testing and genetic profiles in sport applications such as talent identification, individualised training programs and avoidance of sport-related injury.
This resource has been developed to provide information to consumers about the human genome.
The Clinical Practice Guidelines for the management of overweight and obesity in adults, adolescents and children in Australia is intended for use by clinicians including general practitioners.
This document includes NHMRC priorities, the major health issues identified for the 2013-15 period, how NHMRC will deal with those issues and a strategy for medical research and public health research.
The National Health and Medical Research Council (NHMRC) has developed Stem Cell Treatments – A Quick Guide for Medical Practitioners to assist practitioners in discussing stem cell treatments with their patients, and the risks involved in undergoing unproven treatments.
The Quick Guide is supported by the companion document Stem Cell Treatments – Frequently Asked Questions, which provides information for patients about stem cell treatments.
These resources provide information about the regulation of stem cell treatments in Australia that is no longer current. While correct at the time of publication (2013), this information does not reflect changes to the Australian Biologicals Regulatory Framework that came into force from 1 July 2018. Advice will be sought from NHMRC’s Council regarding the future of these documents early in the 2018-21 triennium.
The purpose of the Australian code for the care and use of animals for scientific purposes (the Code) is to promote the ethical, humane and responsible care and use of animals used for scientific purposes. It provides guidance for investigators, institutions, animals ethics committees, animal carers and all those involved in the care and use of animals for scientific purposes. Further information about the background and purpose of the Code is also available.
A PDF version of the Code is available under 'Downloads'
A web version of the Code is provided below.
This Staying healthy: Preventing infectious diseases in early childhood education and care services replaces the 4th edition and represents an increased focus on a risk-management approach to infection prevention and control principles in daily care activities.
The National Health and Medical Research Council (NHMRC) has developed the document Stem Cell Treatments – Frequently Asked Questions to provide consumers with information about stem cell treatments, and the risks involved in undergoing unproven treatments.
The pocket book Infection prevention and control in residential and community aged care provides advice to assistants in nursing, community care, personal care and ancillary staff.
Rapid advances in DNA sequencing technologies now allow an individual’s whole genome to be sequenced.
The Council of NHMRC endorsed the Principles of Peer Review (the Principles) at its 14 March 2013 meeting.
This Clinical Practice Guideline for the management of Borderline Personality Disorder will assist health professionals to diagnose, treat and manage BPD in adolescents and adults.
To ensure we can make healthy food choices, we need dietary advice based on the best scientific evidence. This Guideline seeks to offer the best advice on dietary patterns that promote optimal health and wellbeing for the generally healthy Australian population.
The Guidelines for the management of absolute cardiovascular disease risk consolidate and build upon other evidence and are designed for health practitioners and policy makers.
This paper provides information on the establishment, management and governance of biobanks in Australia. A biobank is a collection of human biological material held for health and medical research. Biobanks facilitate this research, while protecting participants’ interests and privacy.
Clinical Practice Points on the Diagnosis, Assessment and Management of ADHD in Children and Adolescents discusses the use of medications, psychological and educational strategies as other management options for some children/adolescents.
This factsheet aims to support people to: understand the basics of DNA, genes and chromosomes; consider whether to get tested; understand the potential outcomes of the genetic testing process; and find more information and support.
The full title of this factsheet is: DNA Genetic Testing in the Australian Context: A Statement from the National Health and Medical Research Council.
This handbook outlines the requirements and procedures for the certification of institutions under our National Certification Scheme of Institutional Processes Related to the Ethical Review of Multi-centre Research.
The handbook is currently under review. Before commencing steps to apply for certification, please contact us at HREC.firstname.lastname@example.org for further advice.
The Infant Feeding Guidelines are written to assist health workers provide consistent advice about breastfeeding and infant feeding. They provide a review of the evidence, and clear evidence-based recommendations on infant feeding for health workers.
The aim of the statement is to provide the general public with information on the assessment and management of cancer clusters. It is intended to support guidelines issues by State and Territory Departments and Cancer Councils.
Updated in August 2018, the Australian Drinking Water Guidelines (2011) provides guidance to water regulators and suppliers on the preparation and maintenance of a drinking water quality management plan.
The 2010 Legislation review of the Prohibition of Human Cloning for Reproduction Act 2002 and the research involving human embryos Act 2002 offers a review of legislation regarding the use of human clones for reproduction and the use of human embryos in research.
The Procedures and requirements for meeting the 2011 NHMRC standard for clinical practice guidelines are designed to support guideline developers, including those seeking NHMRC approval, to ensure that guidelines are developed to the highest standard.
The Community water planner: A tool for small communities to develop drinking water management plans is a web-based tool made to help assess and manage the risks in remote Australian community water supplies.
Iodine is an essential nutrient that humans need in very small quantities. The thyroid uses iodine to produce hormones vital to ensure normal development of the brain and nervous system before birth, in babies and young children. For this reason, it is very important that pregnant and breastfeeding women get enough iodine.
This brochure for parents provides straightforward information and advice on the importance of all newborn babies to receiving vitamin K.